These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 19726410

  • 1. A comparative study of LRRK2, PINK1 and genetically undefined familial Parkinson's disease.
    Nishioka K, Kefi M, Jasinska-Myga B, Wider C, Vilariño-Güell C, Ross OA, Heckman MG, Middleton LT, Ishihara-Paul L, Gibson RA, Amouri R, Ben Yahmed S, Ben Sassi S, Zouari M, El Euch G, Farrer MJ, Hentati F.
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):391-5. PubMed ID: 19726410
    [Abstract] [Full Text] [Related]

  • 2. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
    Nabli F, Ben Sassi S, Amouri R, Duda JE, Farrer MJ, Hentati F.
    Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA, Davis AA, Jin SC, Ibanez L, Ortega-Cubero S, Pastor P, Choi J, Cooper B, Perlmutter JS, Cruchaga C.
    Mol Neurodegener; 2016 Apr 19; 11():29. PubMed ID: 27094865
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Familial Parkinsonism and early onset Parkinson's disease in a Brazilian movement disorders clinic: phenotypic characterization and frequency of SNCA, PRKN, PINK1, and LRRK2 mutations.
    Camargos ST, Dornas LO, Momeni P, Lees A, Hardy J, Singleton A, Cardoso F.
    Mov Disord; 2009 Apr 15; 24(5):662-6. PubMed ID: 19205068
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S, Mencacci NE, Durán R, Barrero FJ, Escamilla-Sevilla F, Morgan S, Hehir J, Vives F, Hardy J, Pittman AM.
    Neurobiol Aging; 2016 Jan 15; 37():210.e1-210.e5. PubMed ID: 26518746
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dyskinesias in patients with Parkinson's disease: effect of the leucine-rich repeat kinase 2 (LRRK2) G2019S mutation.
    Yahalom G, Kaplan N, Vituri A, Cohen OS, Inzelberg R, Kozlova E, Korczyn AD, Rosset S, Friedman E, Hassin-Baer S.
    Parkinsonism Relat Disord; 2012 Nov 15; 18(9):1039-41. PubMed ID: 22703868
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Role of LRRK2 and SNCA in autosomal dominant Parkinson's disease in Turkey.
    Kessler C, Atasu B, Hanagasi H, Simón-Sánchez J, Hauser AK, Pak M, Bilgic B, Erginel-Unaltuna N, Gurvit H, Gasser T, Lohmann E.
    Parkinsonism Relat Disord; 2018 Mar 15; 48():34-39. PubMed ID: 29248340
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and clinical features of LRRK2 mutations in patients with Parkinson's disease in southern Spain.
    Gao L, Gómez-Garre P, Díaz-Corrales FJ, Carrillo F, Carballo M, Palomino A, Díaz-Martín J, Mejías R, Vime PJ, López-Barneo J, Mir P.
    Eur J Neurol; 2009 Aug 15; 16(8):957-60. PubMed ID: 19473361
    [Abstract] [Full Text] [Related]

  • 15. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.
    Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MD, Misbahuddin A, Chinnery PF, Burn DJ, Clarke CE, Marion MH, Lewthwaite AJ, Nicholl DJ, Wood NW, Morrison KE, Williams-Gray CH, Evans JR, Sawcer SJ, Barker RA, Wickremaratchi MM, Ben-Shlomo Y, Williams NM, Morris HR.
    Mov Disord; 2012 Oct 15; 27(12):1522-9. PubMed ID: 22956510
    [Abstract] [Full Text] [Related]

  • 16. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.
    Somme JH, Molano Salazar A, Gonzalez A, Tijero B, Berganzo K, Lezcano E, Fernandez Martinez M, Zarranz JJ, Gómez-Esteban JC.
    Parkinsonism Relat Disord; 2015 May 15; 21(5):494-9. PubMed ID: 25840672
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Genetics of Parkinson's disease.
    Bonifati V.
    Minerva Med; 2005 Jun 15; 96(3):175-86. PubMed ID: 16175160
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.